Standing at odds: mutated RAS and hematopoietic stem cells

Acute myeloid leukemia (AML) is the most common acute leukemia in adults and is characterized by the accumulation of myeloid leukemic blasts unable to complete differentiation. However, AML is a complex disease with variable outcomes and prognoses.[1][1] Underlying these heterogeneous phenotypes is